Rapamycin treatment decreased the gene expression of MMP-3, MMP-13, IL-1β, IL-6, TNF-α, and protein levels of P16 and P21 in bleomycin-treated AFSCs suggesting that potential of rapamycin for disc degenerative diseases. This evidence concerns the gene IL1B and intervertebral disk degenerative disorder.